573 related articles for article (PubMed ID: 26872862)
1. Meeting report: 4th ISIRV antiviral group conference: Novel antiviral therapies for influenza and other respiratory viruses.
McKimm-Breschkin JL; Fry AM
Antiviral Res; 2016 May; 129():21-38. PubMed ID: 26872862
[TBL] [Abstract][Full Text] [Related]
2. Overview of the 3rd isirv-Antiviral Group Conference--advances in clinical management.
Hurt AC; Hui DS; Hay A; Hayden FG
Influenza Other Respir Viruses; 2015 Jan; 9(1):20-31. PubMed ID: 25399715
[TBL] [Abstract][Full Text] [Related]
3. Influenza virus neuraminidase inhibitors.
Gubareva LV; Kaiser L; Hayden FG
Lancet; 2000 Mar; 355(9206):827-35. PubMed ID: 10711940
[TBL] [Abstract][Full Text] [Related]
4. Influenza polymerase inhibitor resistance: Assessment of the current state of the art - A report of the isirv Antiviral group.
Ison MG; Hayden FG; Hay AJ; Gubareva LV; Govorkova EA; Takashita E; McKimm-Breschkin JL
Antiviral Res; 2021 Oct; 194():105158. PubMed ID: 34363859
[TBL] [Abstract][Full Text] [Related]
5. Advances in respiratory virus therapeutics - A meeting report from the 6th isirv Antiviral Group conference.
Beigel JH; Nam HH; Adams PL; Krafft A; Ince WL; El-Kamary SS; Sims AC
Antiviral Res; 2019 Jul; 167():45-67. PubMed ID: 30974127
[TBL] [Abstract][Full Text] [Related]
6. Antiviral management of seasonal and pandemic influenza.
Hayden FG; Pavia AT
J Infect Dis; 2006 Nov; 194 Suppl 2():S119-26. PubMed ID: 17163384
[TBL] [Abstract][Full Text] [Related]
7. Clinical Implications of Antiviral Resistance in Influenza.
Li TC; Chan MC; Lee N
Viruses; 2015 Sep; 7(9):4929-44. PubMed ID: 26389935
[TBL] [Abstract][Full Text] [Related]
8. Antiviral chemotherapeutic agents against respiratory viruses: where are we now and what's in the pipeline?
Brooks MJ; Sasadeusz JJ; Tannock GA
Curr Opin Pulm Med; 2004 May; 10(3):197-203. PubMed ID: 15071371
[TBL] [Abstract][Full Text] [Related]
9. Antiviral therapy of influenza.
Englund JA
Semin Pediatr Infect Dis; 2002 Apr; 13(2):120-8. PubMed ID: 12122950
[TBL] [Abstract][Full Text] [Related]
10. [Antiviral treatment of influenza in humans].
Nüesch R
Ther Umsch; 2007 Nov; 64(11):635-41. PubMed ID: 18581908
[TBL] [Abstract][Full Text] [Related]
11. Antivirals and influenza: frequency of resistance.
Monto AS
Pediatr Infect Dis J; 2008 Oct; 27(10 Suppl):S110-2. PubMed ID: 18820569
[TBL] [Abstract][Full Text] [Related]
12. Antivirals--current trends in fighting influenza.
Król E; Rychłowska M; Szewczyk B
Acta Biochim Pol; 2014; 61(3):495-504. PubMed ID: 25180220
[TBL] [Abstract][Full Text] [Related]
13. Antiviral Treatments.
Ison MG
Clin Chest Med; 2017 Mar; 38(1):139-153. PubMed ID: 28159156
[TBL] [Abstract][Full Text] [Related]
14. Prevention and treatment of respiratory viral infections: Presentations on antivirals, traditional therapies and host-directed interventions at the 5th ISIRV Antiviral Group conference.
McKimm-Breschkin JL; Jiang S; Hui DS; Beigel JH; Govorkova EA; Lee N
Antiviral Res; 2018 Jan; 149():118-142. PubMed ID: 29162476
[TBL] [Abstract][Full Text] [Related]
15. Antiviral therapy for respiratory viral infections in immunocompromised patients.
Shahani L; Ariza-Heredia EJ; Chemaly RF
Expert Rev Anti Infect Ther; 2017 Apr; 15(4):401-415. PubMed ID: 28067078
[TBL] [Abstract][Full Text] [Related]
16. Clinical applications of antiviral agents for chemophrophylaxis and therapy of respiratory viral infections.
Hayden FG
Antiviral Res; 1985; Suppl 1():229-39. PubMed ID: 2417551
[TBL] [Abstract][Full Text] [Related]
17. Current and novel antiviral strategies for influenza infection.
Yen HL
Curr Opin Virol; 2016 Jun; 18():126-34. PubMed ID: 27344481
[TBL] [Abstract][Full Text] [Related]
18. The neuraminidase inhibitor GS4104 (oseltamivir phosphate) is efficacious against A/Hong Kong/156/97 (H5N1) and A/Hong Kong/1074/99 (H9N2) influenza viruses.
Leneva IA; Roberts N; Govorkova EA; Goloubeva OG; Webster RG
Antiviral Res; 2000 Nov; 48(2):101-15. PubMed ID: 11114412
[TBL] [Abstract][Full Text] [Related]
19. Antiviral drugs in influenza: an adjunct to vaccination in some situations.
Prescrire Int; 2006 Feb; 15(81):21-30. PubMed ID: 16548114
[TBL] [Abstract][Full Text] [Related]
20. Antiviral resistance in influenza viruses--implications for management and pandemic response.
Hayden FG
N Engl J Med; 2006 Feb; 354(8):785-8. PubMed ID: 16495389
[No Abstract] [Full Text] [Related]
[Next] [New Search]
